Skip to main content

Mintz Advises Satellos Bioscience in its US$57.2 Million Initial US Public Offering

Mintz advised Satellos Bioscience Inc. in its US$57.2 million public offering in the United States and Canada and the concurrent listing of its common shares on the Nasdaq Global Market under the trading symbol “MSLE”. Satellos’ common shares are also listed on the Toronto Stock Exchange under the trading symbol “MSCL”.

Leerink Partners, Guggenheim Securities and Oppenheimer & Co. acted as joint book-running managers for the offering. Bloom Burton Securities Inc. acted as co-manager for the offering.

The Mintz cross-border capital markets team included Cheryl Reicin, John Rudy, Matthew Imrie, Alok Choksi, Allyson Wilkinson, Samantha Silver, Gianna Nappi, Ellery O’Hara, Emma Weiss, and Christopher Kinney. Ari Feder and Katy Pitch advised on tax matters and Joanne Hawana advised on regulatory matters. Members of the Mintz team are based in the Toronto, Boston, New York, San Diego and Washington DC offices.